Back
Rallybio Corp. 10K Form
Sell
29
RLYB
Rallybio Corp.
Last Price:
$0.66
Seasonality Move:
-33.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RLYB News And Ratings
See the #1 stock for the next 7 days that we like better than RLYB
RLYB Financial Statistics
Sales & Book Value
| Annual Sales: | $636K |
|---|---|
| Cash Flow: | $-6.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.50 |
| Price / Book: | 0.44 |
Profitability
| EPS (TTM): | -0.31910 |
|---|---|
| Net Income (TTM): | $-14.2M |
| Gross Margin: | $505K |
| Return on Equity: | -23.97% |
| Return on Assets: | -21.88% |
Rallybio Corp. Earnings Forecast
Key Rallybio Corp. Financial Ratios
-
The Gross Profit Margin over the past 6 years for RLYB is 79.40%.
-
The Selling, General & Administrative Expenses for RLYB have been equal to 3,085.69% of Gross Profit Margin.
-
The Research & Development expenses have been 6,505.66% of Revenue.
-
The Net Earning history of RLYB is -9,084.12% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Rallybio Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RLYB |
| Website: | rallybio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 14.74 |
| Quick Ratio: | 13.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RLYB Technical Analysis vs Fundamental Analysis
Sell
29
Rallybio Corp. (RLYB)
is a Sell
Is Rallybio Corp. a Buy or a Sell?
-
Rallybio Corp. stock is rated a SellThe current Rallybio Corp. [RLYB] share price is $0.66. The Score for RLYB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.